Agilent Technologies, MRM Strike Co-marketing Pact | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies said today that it has entered into a co-marketing agreement with MRM Proteomics that will enable the firms to offer more complete hardware, software, and proteomics kit solutions.

Vancouver-based MRM provides protein quantitation, biomarker, and proteomic services to pharmaceutical, biotech, and diagnostics customers. The company specializes in providing highly multiplexed quantitation of proteins in biosamples from blood, cerebrospinal fluid, and urine, using isotopically labeled internal standards.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.